Patients Progressing on an AI ± CDK4/6 Inhibitors: From Biomarkers to Treatment Strategies Podcast Por  arte de portada

Patients Progressing on an AI ± CDK4/6 Inhibitors: From Biomarkers to Treatment Strategies

Patients Progressing on an AI ± CDK4/6 Inhibitors: From Biomarkers to Treatment Strategies

Escúchala gratis

Ver detalles del espectáculo

Obtén 3 meses por US$0.99 al mes

Did you know that the prevalence of acquired ESR1 mutations increases after exposure to endocrine therapy?

Credit available for this activity expires: 11/26/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/advancing-copd-care-through-precision-medicine-and-patient-2025a1000x00?ecd=bdc_podcast_libsyn_mscpedu

Todavía no hay opiniones